Management of patients with chronic renal insufficiency in the Northeastern United States

Journal of the American Society of Nephrology

Volumn 12, Issue 7, 2001, Pages 1501-1507

  Kausz, A T ^a   Khan, S S ^a   Abichandani, R ^a   Kazmi, W H ^a   Obrador, G T ^a   Ruthazer, R ^a   Pereira, B J G ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; CALCIUM METABOLISM; CHRONIC KIDNEY FAILURE; COMORBIDITY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE METABOLISM; PRIORITY JOURNAL; UNITED STATES;

EID: 0034918872     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. The next ten years of health spending: What does the future hold?
2. The social contract and the treatment of permanent kidney failure
3. Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis
4. Nutrition and mortality in hemodialysis
5. Serum creatinine levels in the US population: Third national health and nutrition examination survey
6. Multidisciplinary predialysis programs: Quantification and limitations of their impact on patient outcomes in two Canadian settings
7. Optimization of pre-ESRD care: The key to improved dialysis outcomes
8. Recent developments and future issues in the use of health status assessment measures in clinical setting
9. Comorbidity assessment in hemodialysis and peritoneal dialysis using the Index of Coexistent Disease
10. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
11. Predictors of the progression of renal disease in the modification of diet in renal disease study
12. Morbidity and mortality of renal dialysis: An NIH consensus conference statement
13. Spontaneous dietary protein intake during progression of chronic renal failure
14. 2D
15. The importance of dietary calcium and phosphorus in the secondary hyperparathyroidism of patients with early renal failure
16. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention
17. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy
18. Effect of angiotensin-convertingenzyme inhibitors on the progression of non-diabetic renal disease: A meta-analysis of randomized trials
19. Blood pressure, proteinuria, and the progression of renal disease
20. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease
21. Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complications trial
22. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria
23. Renal protective effects of enalapril in hypertensive NIDDM: Role of baseline albuminuria
24. Screening and management of microalbuminuria in patients with diabetes mellitus: Recommendations to the Scientific Advisory Board of the National Kidney Foundation from the Ad hoc Committee of the Council on Diabetes Mellitus of the National Kidney Foundation
25. Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: Important differences between practice and published guidelines
26. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V)
27. The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
28. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities
29. Morbidity and mortality in dialysis patients
30. The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease
31. A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia
32. Atherosclerosis in uremia: Possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation
33. Long-term complications of diabetes mellitus
34. Hematocrit levels and hospitalization risk in hemodialysis patients
35. Hematocrit level and associated mortality in hemodialysis patients
36. Prevalence of and factors associated with sub-optimal care prior to initiation of dialysis in the United States
37. Late referral for maintenance dialysis
38. Prevalence, predictors and consequences of late nephrology referral at a tertiary care center
39. Hospital utilization among chronic dialysis patients
40. Assessing adequacy of vascular access and its relationship to patient outcome
41. The cost of hospitalizations due to hemodialysis access management
42. An analysis of the adequacy of preparation for end-stage renal disease care in Michigan